back up series mGluR4 (Prexton Therapeutics)

N/A

Report date: 2025/01/26 15:01:51
NME

Base Information

Drug Nameback up series mGluR4 (Prexton Therapeutics)
Drug Alias NamemGluR4 PAMs (Prexton Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMetabotropic glutamate receptor 4 modulators
TargetsMetabotropic glutamate receptor 4
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPrexton Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesPrexton Therapeutics
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A